These ROS play a role in cell signaling and can influence tumor progression and resistance to therapies, particularly in cancers like non-small-cell lung cancer (NSCLC), where they are linked to EGFR-TKI resistance [13]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.